Get the inside scoop now.
Adipose-Derived Stem Cell Exosomes
for Treatment of Dupilumab-Related Facial Redness in Patients with Atopic Dermatitis Han, Hye Sung et al. The Journal of dermatological treatment vol. 34,1 (2023): 2220444. doi:10.1080/09546634.2023.2220444 |
|
|
In the most recent study on BENEV Exosomes, Han et al. examined the efficacy of human adipose tissue-derived mesenchymal stem cell (MSC)-derived exosomes (ASCEs) in treating dupilumab facial redness (DFR), which is a side effect of dupilumab treatment for atopic dermatitis (AD). Researchers examined twenty patients for DFR improvement from topical exosome applications. |
|
|
Clinical Results Topically applying BENEV Exosomes "quickly resolves DFR symptoms" Exosomes were found to downregulate local inflammation and restore skin barrier function BENEV Exosomes demonstrated great potential in DFR treatment
| | |
|
|
"Quality control, skin toxicity, manufacturing process—this is why BENEV Exosomes are the best to offer in your practice." Saami Khalifian, MD NEW BENEV Exosomes Provider |
|
|
Using the EXO Balm, patients can now bring home the benefits of exosomes. This compact formula can easily be stored in the refrigerator and topically applied until patients' post treatment recovery is complete and their skin has that signature glow. Find out how you can optimize EXO Balm for your practice in our recent blog. |
|
|
|
|
You've received this email because you are a subscriber of this site. | If you feel you received it by mistake or wish to unsubscribe, please click here. |
|
|
